You are here » Home » Companies » Company Overview » Godavari Drugs Ltd

Godavari Drugs Ltd.

BSE: 530317 Sector: Health care
NSE: N.A. ISIN Code: INE362C01012
BSE 00:00 | 24 Jan 62.30 -3.85
(-5.82%)
OPEN

65.20

HIGH

66.60

LOW

61.65

NSE 05:30 | 01 Jan Godavari Drugs Ltd
OPEN 65.20
PREVIOUS CLOSE 66.15
VOLUME 9259
52-Week high 83.60
52-Week low 38.10
P/E 9.51
Mkt Cap.(Rs cr) 47
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 65.20
CLOSE 66.15
VOLUME 9259
52-Week high 83.60
52-Week low 38.10
P/E 9.51
Mkt Cap.(Rs cr) 47
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Godavari Drugs Ltd. (GODAVARIDRUGS) - Company History

Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole (SMX) the main product of the company is a widely used anti-bacterial drug enjoying good export demand.The company has expanded its SMX capacity from 540 tpa to 720 tpa integrating backward into the manufacture of drug intermediates sulphamethoxide (cap.: 450 tpa) and diethyl oxalate DEO (cap.: 750 tpa) and diversifying into the manufacture of trimetroprim TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact Siris and Chemox Chemicals both having good capacities of SMX have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactumwhich is a intermediate used to produce Diltiazem an anti anginal drug.

.